IRVINE, Calif., Oct. 9, 2014 (GLOBE NEWSWIRE) -- Praxsyn Corporation (OTCQB:PXYN), has appointed Kelly Reynolds to the position of Chief Executive Officer and Manager of NexGen Med Solutions, LLC, a wholly owned subsidiary of Praxsyn Corporation.
NexGen Med Solutions, a billing and collections company, was recently formed to allow Praxsyn to manage its accounts receivables in a more cost-effective and efficient manner. The new subsidiary is anticipated to provide an integrated alternative to previous billing and collections procedures.
Ms. Reynolds, the current Chief Administrative Officer of Mesa Pharmacy, Inc., has worked in the pharmacy business for more than five years with expertise in medical billing, data management and day-to-day operations of all administrative functions of Mesa Pharmacy. In particular, she has been developing internal systems for the billing and receiving of medical prescriptions, and the daily management of patient records, accounts receivable and prescriptions verification. During the past three years, Ms. Reynolds has developed a systemized billing system in which the patients billing information is compiled and verified for accuracy, and then billed electronically to the insurance carrier.
"We are excited to build out the collection component of the company through NexGen and we anticipate that NexGen will be part of our overall growth and success of the company," said Reynolds. "Incorporating NexGen as the in-house billing company will provide Praxsyn with an expanded footprint to grow its existing business as well as further leverage the company's potential for future earnings."
NexGen Med Solutions, LLC was established on August 18, 2014, as a wholly owned subsidiary of Praxsyn Corporation, and is located in Southern California.
About Praxsyn Corporation
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.
CONTACT: Media/Investor Contact: IR@PraXsyn.com 949-777-6112 ext 101